Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history and the previous entry v3.6.2 was removed, updating the displayed version history.SummaryDifference0.1%

- Check12 days agoChange DetectedA new revision entry v3.6.2 was added to the record history, and the previous v3.6.0 entry was removed. This updates the page's version history without changing the underlying study information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedEnrollment is now closed to new participants, and the history shows a new revision (v3.6.0) was added while the previous revision (v3.5.5) was removed.SummaryDifference0.2%

- Check33 days agoChange DetectedA new revision entry (v3.5.5) was added to the history, updating the record's version list. The previous revision (v3.5.4) was removed from the history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record history now shows a new revision entry v3.5.4 and removes v3.5.3 from the list. This reflects an internal update to the page's versioning.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page’s interface/version indicator was updated from revision v3.5.2 to v3.5.3, reflecting a maintenance or UI release rather than a change to the trial record itself.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.